PHARMACY

Appeals court reverses district court decision on Altace

BY Drew Buono

A federal appeals court has reversed a decision made by the U.S. District Court for the Eastern District of Virginia, which had found that Lupin Pharmaceuticals had infringed on a compound patent of King Pharmaceuticals’ hypertension drug Altace under the doctrine of equivalents due to obviousness.

The ‘722 patent covers a stereoisomer of ramipril, the key ingredient in Altace. Circuit Judge Richard Linn explained that a stereoisomer, “is an isomer in which the same atoms are bonded to the same other atoms, but where the configuration of those atoms in three dimensions differ.”

Linn decided that Aventis, who King licensed the patent from, failed to “rebut this prima facie case of obviousness by arguing that purified 5(S) ramipril exhibited unexpected results.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

CVS to offer flu vaccinations in more than 4,000 stores

BY Allison Cerra

WOONSOCKET, R.I. CVS/pharmacy plans to help Americans stay healthy by offering flu vaccinations in over 4,000 of its stores, the company said Wednesday.

The flu vaccinations, which will be offered to customers by Oct. 1, will vary in cost based on location. Vaccines for Medicare Part B beneficiaries who present their Medicare Card will be available at no charge, provided they have not assigned their Medicare benefits to a private Health Maintenance Organization. The offer to receive the flu shots will run through November.

“The annual flu shot clinics at CVS/pharmacy are part of our commitment to help communities stay healthy,” said Papatya Tankut, R.Ph., Vice President of Pharmacy Professional Services at CVS/pharmacy. “By offering convenient locations for flu vaccinations, we’re providing additional opportunities for people across the country to get vaccinated before the peak flu season begins.”

Last year, nearly 400,000 people received flu shots at CVS/pharmacy.

It is strongly recommended people ages 50 and older, and/or have chronic illnesses like diabetes and asthma, receive a yearly flu vaccination, according to the Centers for Disease Control.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Adams, Lipocine to develop new cough medicines

BY Drew Buono

CHESTER, N.J. Lipocine and Adams Respiratory Therapeutics have entered in an agreement to develop new prescription adult cough products.

Under the terms of the agreement, Adams receives exclusive rights from Lipocine to develop and market multiple prescription adult cough products. Adams will be responsible for performing clinical development, regulatory submission, manufacture, and commercial operations. Lipocine will be responsible for completing the product development work.

Lipocine will have the opportunity to receive reimbursements and payments in exchange for completing development milestones. “Given the large and growing size of the respiratory market, and how patients can benefit from enhanced dosage forms and regimens, we are very pleased to partner with Adams, a company highly respected for its commercialization accomplishments,” said Dr. Mahesh Patel, president and chief executive officer of Lipocine.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES